Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Revenue: 2022-2025

Historic Revenue for Dianthus Therapeutics (DNTH) over the last 3 years, with Sep 2025 value amounting to $396,000.

  • Dianthus Therapeutics' Revenue fell 81.77% to $396,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 42.31%. This contributed to the annual value of $6.2 million for FY2024, which is 120.63% up from last year.
  • According to the latest figures from Q3 2025, Dianthus Therapeutics' Revenue is $396,000, which was up 105.18% from $193,000 recorded in Q2 2025.
  • Dianthus Therapeutics' 5-year Revenue high stood at $2.2 million for Q3 2024, and its period low was $193,000 during Q2 2025.
  • In the last 3 years, Dianthus Therapeutics' Revenue had a median value of $924,000 in 2023 and averaged $985,182.
  • Per our database at Business Quant, Dianthus Therapeutics' Revenue soared by 211.27% in 2024 and then crashed by 89.64% in 2025.
  • Dianthus Therapeutics' Revenue (Quarterly) stood at $1.2 million in 2022, then crashed by 63.74% to $426,000 in 2023, then soared by 211.27% to $1.3 million in 2024, then slumped by 81.77% to $396,000 in 2025.
  • Its Revenue was $396,000 in Q3 2025, compared to $193,000 in Q2 2025 and $1.2 million in Q1 2025.